The Institute of Cancer Research Selects the Labcyte Inc. Access™ Laboratory Workstation for Enhancing its Drug Discovery Capabilities  
7/31/2012 10:10:11 AM

SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte has announced that The Institute of Cancer Research (ICR) has implemented its Access workstation to automate the production of low-volume, assay-ready microplates from high-throughput screening and fragment libraries for biochemical, cell-based, and biophysical screening.